HopeStage
Back to all studies
TerminatedNCT01663974

Evaluation of Sub-syndromal Symptoms After Acute Depressive Episode in Bipolarity

Observational studyAges 18+France
The study in practice

Understand this study

Who could participate?

This study is for people with bipolarity. Listed age limits: from 18 years. Other eligibility criteria apply.

Listed locations
Aix-en-Provence and 85 more locationsSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateApril 2013
Recruitment status
Terminated
Enrollment listed in the registry
125
Sponsor
AstraZeneca
Sponsor type
Unknown or unclear
Study type
Observational
Intervention type
Interview / survey / observational
Study phase
Not clearly listed
Locations
France
Age range
Over 18 Years
Official registry ID
NCT01663974
Official title
Show the full official title

Evaluation of Sub-syndromal Symptoms After Acute Depressive Episode in Bipolar Disorder

Recruitment & locations

Terminated

Aix-en-Provence · Ajaccio · Altkirch

83 more locations
  • Armentières
  • Avignon
  • Bailleul
  • Bohars
  • Bordeaux
  • Bourg-en-Bresse
  • Brest
  • Caen
  • Cahors
  • Castries
  • Challes-les-Eaux
  • Châteaulin
  • Clermont-Ferrand
  • Colmar
  • Conty
  • Coulommiers
  • Créteil
  • Crosne
  • Dax
  • Décines-Charpieu
  • Digne-les-Bains
  • Douai
  • Durtol
  • Dury
  • Fains-Véel
  • Fitz-James
  • Grenoble
  • Hazebrouck
  • Héricourt
  • Issoudun
  • La Roche-sur-Foron
  • La Roche-sur-Yon
  • La Rochelle
  • La Tronche
  • La Varenne-Saint-Hilaire
  • Lamballe
  • Laval
  • Le Mans
  • Le Puy-en-Velay
  • Le Vésinet
  • Libourne
  • Limoges
  • Luynes
  • Lyon
  • Marseille
  • Mayenne
  • Metz
  • Monaco
  • Mont-de-Marsan
  • Montfermeil
  • Montmorency
  • Montpellier
  • Nancy
  • Nemours
  • Nevers
  • Nice
  • Noisiel
  • Novillars
  • Paimpol
  • Paris
  • Pau
  • Reims
  • Rouffach
  • Rueil-Malmaison
  • Saint-Denis
  • Saint-Denis-lès-Bourg
  • Saint-Dizier
  • Saint-Égrève
  • Saint-Nazaire
  • Saint-Vincent-de-Tyrosse
  • Sallanches
  • Sevrey
  • Soissons
  • Sotteville-lès-Rouen
  • Strasbourg
  • Thuir
  • Toulon
  • Toulouse
  • Tours
  • Valence
  • Vernon
  • Versailles
  • Vincennes
FAQ

Questions about this study

Who is behind this study?

The study sponsor is AstraZeneca.

Who can participate?

This study is for people with bipolarity. Listed age limits: from 18 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies